<DOC>
	<DOCNO>NCT01191632</DOCNO>
	<brief_summary>The efficiency T cell base immunotherapy affect insufficient migration activity tumor specific effector T cell tumor . Aim phase I/II clinical trial evaluate whether neoadjuvant , low dose radiotherapy improve T cell connect anti tumor immune response colorectal liver metastasis . The primary endpoint number tumor infiltrate T cell . Furthermore T cell activity situ , number regulatory T cell frequency tumor reactive T cell blood bone marrow examine .</brief_summary>
	<brief_title>Effect Neoadjuvant Radiation Tumor Infiltrating T-cells Low Dose Radiation Colorectal Liver Metastases</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>Ability subject understand character individual consequence clinical trial Written inform consent ( must available enrolment trial ) Age â‰¥ 50 year Radiological urgently suspect colorectal liver metastasis second malignancy Pregnancy lactation prior liver radiation liver metastasis must resectable</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>T cell</keyword>
	<keyword>surgery</keyword>
	<keyword>radiation</keyword>
</DOC>